AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
MONDAY, Oct. 26, 2020 (HealthDay News) — Drugmakers AstraZeneca and Johnson & Johnson...
Read MoreOct 27, 2020
MONDAY, Oct. 26, 2020 (HealthDay News) — Drugmakers AstraZeneca and Johnson & Johnson...
Read MoreOct 27, 2020
MONDAY, Oct. 26, 2020 (HealthDay News) — Finerenone results in a lower risk for chronic...
Read MoreOct 26, 2020
FRIDAY, Oct. 23, 2020 (HealthDay News) — Vaccination coverage with many recommended vaccines...
Read MoreOct 26, 2020
FRIDAY, Oct. 23, 2020 (HealthDay News) — For patients with moderate COVID-19, convalescent...
Read MoreOct 26, 2020
FRIDAY, Oct. 23, 2020 (HealthDay News) — For patients with psoriasis, survival from COVID-19...
Read MoreOct 26, 2020
FRIDAY, Oct. 23, 2020 (HealthDay News) — Tocilizumab may be beneficial for adults with...
Read MoreOct 26, 2020
FRIDAY, Oct. 23, 2020 (HealthDay News) — In a Society for Healthcare Epidemiology of America...
Read MoreOct 26, 2020
FRIDAY, Oct. 23, 2020 (HealthDay News) — At a meeting of the U.S. Food and Drug...
Read MoreOct 26, 2020
FRIDAY, Oct. 23, 2020 (HealthDay News) — When a COVID-19 vaccine becomes available, the U.S....
Read MoreOct 26, 2020
FRIDAY, Oct. 23, 2020 (HealthDay News) — The majority of older women can tolerate surgery...
Read MoreOct 26, 2020
ANESTHESIOLOGY 2020 The annual meeting of the American Society of Anesthesiologists was held...
Read MoreOct 26, 2020
The 105th Annual American College of Surgeons Clinical Congress The annual meeting of the American...
Read MoreOct 23, 2020
WEDNESDAY, Oct. 21, 2020 (HealthDay News) — For patients with asthma, oral corticosteroid...
Read MoreOct 23, 2020
THURSDAY, Oct. 22, 2020 (HealthDay News) — For moderately ill hospitalized patients with...
Read MoreOct 23, 2020
THURSDAY, Oct. 22, 2020 (HealthDay News) — For women with breast cancer, colorectal cancer,...
Read MoreOct 23, 2020
THURSDAY, Oct. 22, 2020 (HealthDay News) — Chemotherapy-free induction and consolidation first-line treatment with dasatinib and blinatumomab is associated with a high incidence of molecular response and survival in adults...
Read MoreOct 23, 2020
THURSDAY, Oct. 22, 2020 (HealthDay News) — The first company to start a phase 3 trial of a...
Read MoreOct 23, 2020
Even among HIV-focused practitioners, preexposure prophylaxis (PrEP) prescribing is not routine,...
Read MoreOct 22, 2020
WEDNESDAY, Oct. 21, 2020 (HealthDay News) — Purdue Pharma, maker of the opioid painkiller...
Read MoreOct 22, 2020
WEDNESDAY, Oct. 21, 2020 (HealthDay News) — Anthony Fauci, M.D., the leading infectious...
Read More